基本信息
浏览量:2
![](https://originalfileserver.aminer.cn/sys/aminer/icon/show-trajectory.png)
个人简介
My clinical and academic interests are focused primarily on inflammatory neuropathy. The inflammatory neuropathies include Guillian-Barre Syndrome (GBS), chronic inflammatory demyelinating polyneuropathy (CIDP), and multifocal motor neuropathy (MMN). Through various studies I hope to improve the techniques that we use to diagnose inflammatory neuropathy and to find new and improved ways to treat inflammatory neuropathy. This includes both investigation of new medications as well as improving the way we utilize standard medications. Every person is different; with different treatment requirements, different reactions to medications, and different goals for treatment. Much of my research aims to customize treatment to individual patient needs so that we can optimize treatment outcomes on an individual level.
研究兴趣
论文共 357 篇作者统计合作学者相似作者
按年份排序按引用量排序主题筛选期刊级别筛选合作者筛选合作机构筛选
时间
引用量
主题
期刊级别
合作者
合作机构
Yazmin Odia, Carl Koschmann, Nicholas A. Vitanza, Peter de Blank, Dolly Aguilera,Jeffrey Allen, Doured Daghistani,Matthew Hall, Ziad Khatib,Cassie Kline,Tobey Macdonald, Sabine Mueller,
NEURO-ONCOLOGYno. Supplement_2 (2024): S155-S164
Michael J Fisher,Peter de Blank,Robert Listernick,Grant Liu,Rosalie Ferner,David Gutmann, Janice Lasky-Zeid,Nicole Ullrich,Gena Heidary,Miriam Bornhorst,Steven Stasheff, Teena Rosser,
Neuro-Oncologyno. Supplement_4 (2024): 0-0
Mayo Clinic Proceedings: Innovations, Quality & Outcomesno. 1 (2024): 74-81
Current opinion in neurology (2024)
Nicole M. Warrington,Tao Sun,Jingqin Luo,Robert C. McKinstry,Patricia C. Parkin, Sara Ganzhorn, Debra Spoljaric,Anne C. Albers,Amanda Merkelson,Douglas R. Stewart,David A. Stevenson,David Viskochil,
openalex(2023)
Neuro-oncology advancesno. 1 (2023)
加载更多
作者统计
#Papers: 332
#Citation: 23394
H-Index: 75
G-Index: 147
Sociability: 8
Diversity: 0
Activity: 2
合作学者
合作机构
D-Core
- 合作者
- 学生
- 导师
数据免责声明
页面数据均来自互联网公开来源、合作出版商和通过AI技术自动分析结果,我们不对页面数据的有效性、准确性、正确性、可靠性、完整性和及时性做出任何承诺和保证。若有疑问,可以通过电子邮件方式联系我们:report@aminer.cn